TransCode Therapeutics In...

NASDAQ: RNAZ · Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.98
0.09%
After-hours: Aug 15, 2025, 03:59 PM EDT

TransCode Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.4 -1.25 -160.8 -1.99K
PEG Ratio
0.01 0.01 -0.01 -16.54
PS Ratio
n/a n/a n/a n/a
PB Ratio
-11.66 14.10 1.74K 678.39
P/FCF Ratio
-1.76 -1.28 -356.09 -2.51K
P/OCF Ratio
-1.76 -1.28 -358.37 -2.63K
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
-0.02 0.27 n/a n/a
Quick Ratio
2.56 1.28 1.57 8.97
Current Ratio
2.56 1.28 1.70 8.97
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-584.07 -347.39 -1.06 -64.7
Return on Equity
8.30 -11.3 -10.84 -0.34
Return on Assets
-2.3 -3.59 -4.63 -0.3
Return on Invested Capital
-3.43 -9.29 -11.52 -0.31
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a